rs78780803

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378213.1(BCL9L):​c.1627A>G​(p.Ser543Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0134 in 1,613,902 control chromosomes in the GnomAD database, including 467 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S543N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.022 ( 86 hom., cov: 32)
Exomes 𝑓: 0.013 ( 381 hom. )

Consequence

BCL9L
NM_001378213.1 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.92

Publications

10 publications found
Variant links:
Genes affected
BCL9L (HGNC:23688): (BCL9 like) Enables beta-catenin binding activity. Involved in several processes, including negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of epithelial to mesenchymal transition; and positive regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001069814).
BP6
Variant 11-118902116-T-C is Benign according to our data. Variant chr11-118902116-T-C is described in ClinVar as Benign. ClinVar VariationId is 402417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCL9LNM_001378213.1 linkc.1627A>G p.Ser543Gly missense_variant Exon 8 of 10 ENST00000683865.1 NP_001365142.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCL9LENST00000683865.1 linkc.1627A>G p.Ser543Gly missense_variant Exon 8 of 10 NM_001378213.1 ENSP00000507778.1 Q86UU0-1
BCL9LENST00000334801.7 linkc.1627A>G p.Ser543Gly missense_variant Exon 6 of 8 1 ENSP00000335320.3 Q86UU0-1
BCL9LENST00000526143.2 linkc.1516A>G p.Ser506Gly missense_variant Exon 6 of 8 5 ENSP00000482938.1 A0A087WZX0
BCL9LENST00000530293.1 linkn.41-1355A>G intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.0224
AC:
3403
AN:
151966
Hom.:
86
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0364
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00857
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.114
Gnomad SAS
AF:
0.0166
Gnomad FIN
AF:
0.0495
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00777
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0218
AC:
5470
AN:
251150
AF XY:
0.0208
show subpopulations
Gnomad AFR exome
AF:
0.0368
Gnomad AMR exome
AF:
0.00379
Gnomad ASJ exome
AF:
0.00477
Gnomad EAS exome
AF:
0.129
Gnomad FIN exome
AF:
0.0443
Gnomad NFE exome
AF:
0.00703
Gnomad OTH exome
AF:
0.0129
GnomAD4 exome
AF:
0.0125
AC:
18281
AN:
1461816
Hom.:
381
Cov.:
36
AF XY:
0.0126
AC XY:
9134
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.0355
AC:
1190
AN:
33480
American (AMR)
AF:
0.00461
AC:
206
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00352
AC:
92
AN:
26136
East Asian (EAS)
AF:
0.0910
AC:
3613
AN:
39700
South Asian (SAS)
AF:
0.0163
AC:
1410
AN:
86252
European-Finnish (FIN)
AF:
0.0422
AC:
2254
AN:
53366
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.00758
AC:
8425
AN:
1111998
Other (OTH)
AF:
0.0174
AC:
1053
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1126
2251
3377
4502
5628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0224
AC:
3413
AN:
152086
Hom.:
86
Cov.:
32
AF XY:
0.0242
AC XY:
1797
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0366
AC:
1518
AN:
41484
American (AMR)
AF:
0.00856
AC:
131
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3468
East Asian (EAS)
AF:
0.114
AC:
583
AN:
5136
South Asian (SAS)
AF:
0.0166
AC:
80
AN:
4810
European-Finnish (FIN)
AF:
0.0495
AC:
524
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00777
AC:
528
AN:
67980
Other (OTH)
AF:
0.0133
AC:
28
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
168
336
504
672
840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0132
Hom.:
113
Bravo
AF:
0.0206
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.0370
AC:
163
ESP6500EA
AF:
0.00733
AC:
63
ExAC
AF:
0.0206
AC:
2506
Asia WGS
AF:
0.0550
AC:
189
AN:
3478
EpiCase
AF:
0.00616
EpiControl
AF:
0.00611

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
18
DANN
Benign
0.83
DEOGEN2
Benign
0.082
T;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.25
T;T
MetaRNN
Benign
0.0011
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.69
N;.
PhyloP100
1.9
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.36
N;.
REVEL
Benign
0.11
Sift
Benign
0.40
T;.
Sift4G
Benign
0.62
T;T
Polyphen
0.0
B;.
Vest4
0.083
MPC
0.18
ClinPred
0.000036
T
GERP RS
4.6
Varity_R
0.030
gMVP
0.12
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78780803; hg19: chr11-118772825; COSMIC: COSV52689277; COSMIC: COSV52689277; API